Adaptation of the WOMAC for Use in a Patient Preference Study.
Sarah Stothers RosenbergXinyi NgCarol MansfieldChristine PoulosHolly PeayTing-Hsuan LeeTelba IronyMartin HoPublished in: Therapeutic innovation & regulatory science (2023)
This study adds to the growing literature regarding adapting PRO measures for patient preference studies. Such adaptation is important for designing a preference study that can incorporate a clinical trial's outcomes with PRO endpoints.